BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26240978)

  • 1. A PMS2-specific colorectal surveillance guideline.
    ten Broeke SW; Nielsen M
    Genet Med; 2015 Aug; 17(8):684. PubMed ID: 26240978
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hicks SC; Ward RL; Hawkins NJ
    Pathology; 2011 Jan; 43(1):84-5; author reply 85-6. PubMed ID: 21240077
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression.
    Clendenning M; Macrae FA; Walsh MD; Walters RJ; Thibodeau SN; Gunawardena SR; Potter JD; Haile RW; Gallinger S; ; Hopper JL; Jenkins MA; Rosty C; Young JP; Buchanan DD
    Clin Genet; 2013 Jun; 83(6):591-3. PubMed ID: 23017166
    [No Abstract]   [Full Text] [Related]  

  • 4. PMS2 mutations in childhood cancer.
    Bonthron DT; Hayward BE; De Vos M; Sheridan E
    Gut; 2005 Dec; 54(12):1821. PubMed ID: 16284300
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer.
    Truninger K; Menigatti M; Luz J; Russell A; Haider R; Gebbers JO; Bannwart F; Yurtsever H; Neuweiler J; Riehle HM; Cattaruzza MS; Heinimann K; Schär P; Jiricny J; Marra G
    Gastroenterology; 2005 May; 128(5):1160-71. PubMed ID: 15887099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
    Leong V; Lorenowicz J; Kozij N; Guarné A
    Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
    Li L; Hamel N; Baker K; McGuffin MJ; Couillard M; Gologan A; Marcus VA; Chodirker B; Chudley A; Stefanovici C; Durandy A; Hegele RA; Feng BJ; Goldgar DE; Zhu J; De Rosa M; Gruber SB; Wimmer K; Young B; Chong G; Tischkowitz MD; Foulkes WD
    J Med Genet; 2015 May; 52(5):348-52. PubMed ID: 25691505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical problem-solving. Spot diagnosis.
    Stark Z; Campbell LJ; Mitchell C; James PA; Heath JA; Boussioutas A; Lynch C; Trainer AH
    N Engl J Med; 2014 Jun; 370(23):2229-36. PubMed ID: 24897087
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with café-au-lait spots caused by a novel homozygous PMS2 mutation.
    Kratz CP; Niemeyer CM; Jüttner E; Kartal M; Weninger A; Schmitt-Graeff A; Kontny U; Lauten M; Utzolino S; Rädecke J; Fonatsch C; Wimmer K
    Leukemia; 2008 May; 22(5):1078-80. PubMed ID: 18007577
    [No Abstract]   [Full Text] [Related]  

  • 11. PMS2 mutations in HNPCC.
    Hayward BE; De Vos M; Sheridan E; Bonthron DT
    Clin Genet; 2004 Dec; 66(6):566-7; author reply 568. PubMed ID: 15521988
    [No Abstract]   [Full Text] [Related]  

  • 12. An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers.
    Goel A; Nagasaka T; Hamelin R; Boland CR
    PLoS One; 2010 Feb; 5(2):e9393. PubMed ID: 20195377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
    Shia J; Tang LH; Vakiani E; Guillem JG; Stadler ZK; Soslow RA; Katabi N; Weiser MR; Paty PB; Temple LK; Nash GM; Wong WD; Offit K; Klimstra DS
    Am J Surg Pathol; 2009 Nov; 33(11):1639-45. PubMed ID: 19701074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
    Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
    Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
    Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
    J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline PMS2 mutations: one hit or two?
    Gryfe R; Gallinger S
    Gastroenterology; 2005 May; 128(5):1506-9. PubMed ID: 15887130
    [No Abstract]   [Full Text] [Related]  

  • 17. Germline mutation and protein expression analysis of mismatch repair genes MSH6 and PMS2 in Malaysian Lynch syndrome patients.
    Zahary MN; Kaur G; Hassan MR; Sidek AS; Singh H; Yeh LY; Ankathil R
    Int J Colorectal Dis; 2014 Feb; 29(2):261-2. PubMed ID: 24072394
    [No Abstract]   [Full Text] [Related]  

  • 18. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer.
    Will O; Carvajal-Carmona LG; Gorman P; Howarth KM; Jones AM; Polanco-Echeverry GM; Chinaleong JA; Günther T; Silver A; Clark SK; Tomlinson I
    Gastroenterology; 2007 Feb; 132(2):527-30. PubMed ID: 17258725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA mismatch repair and colon cancer.
    Marra G; Jiricny J
    Adv Exp Med Biol; 2005; 570():85-123. PubMed ID: 18727499
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression.
    Chen PC; Kuraguchi M; Velasquez J; Wang Y; Yang K; Edwards R; Gillen D; Edelmann W; Kucherlapati R; Lipkin SM
    PLoS Genet; 2008 Jun; 4(6):e1000092. PubMed ID: 18551179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.